• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实时 RT-PCR 分析用于评估乳腺癌中的 Her2/neu 状态。

Real-time RT-PCR analysis for evaluating the Her2/neu status in breast cancer.

机构信息

Department of Computational Science and Artificial Intelligence, University of Granada, ES-18071 Granada, Spain. cuadroslujan @ yahoo.es

出版信息

Pathobiology. 2010;77(1):38-45. doi: 10.1159/000272953. Epub 2010 Feb 25.

DOI:10.1159/000272953
PMID:20185966
Abstract

OBJECTIVE

The Her2/neu status is of great clinical value in breast tumor patients. Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) techniques are the test of choice for many practicing pathologies. The main objective of this retrospective study was to investigate the relationship between Her2/neu breast cancer amplification and overexpression (DNA, mRNA and protein).

METHODS

To accomplish this goal, we evaluated Her2/neu mRNA expression by real-time quantitative RT-PCR, gene amplification by FISH and protein expression by IHC.

RESULTS

An excellent correlation between FISH and IHC Her2/neu results was observed, confirming that protein levels were directly related to DNA amplification. Polysomy 17 was frequently found in tumors showing Her2/neu overexpression. However, we did not find any statistically significant correlation among DNA, mRNA and protein levels, suggesting that Her2/neu could be post-transcriptionally regulated.

CONCLUSIONS

There was a highagreement between Her2/neu gene amplification and protein overexpression but not mRNA expression levels. Nevertheless, IHC3+ and FISH-positive tumors indicated higher expression levels of Her2/neu mRNA by RT-PCR than those observed in IHC and FISH-negative tumors. These findings question the relevance of quantitative RT-PCR in routine assessment of Her2/neu overexpression in human breast cancer in the clinical laboratory setting.

摘要

目的

Her2/neu 状态在乳腺肿瘤患者中具有重要的临床价值。荧光原位杂交(FISH)和免疫组织化学(IHC)技术是许多临床病理的首选检测方法。本回顾性研究的主要目的是研究 Her2/neu 乳腺癌扩增与过表达(DNA、mRNA 和蛋白质)之间的关系。

方法

为了实现这一目标,我们通过实时定量 RT-PCR 评估 Her2/neu mRNA 表达,通过 FISH 评估基因扩增,通过 IHC 评估蛋白质表达。

结果

观察到 FISH 和 IHC Her2/neu 结果之间存在极好的相关性,证实蛋白质水平与 DNA 扩增直接相关。在 Her2/neu 过表达的肿瘤中经常发现 17 号染色体三体。然而,我们没有发现 DNA、mRNA 和蛋白质水平之间存在任何统计学上的显著相关性,表明 Her2/neu 可能受到转录后调控。

结论

Her2/neu 基因扩增与蛋白过表达之间具有高度一致性,但与 mRNA 表达水平不一致。然而,IHC3+和 FISH 阳性肿瘤的 Her2/neu mRNA 表达水平通过 RT-PCR 高于 IHC 和 FISH 阴性肿瘤。这些发现质疑在临床实验室环境中,定量 RT-PCR 在常规评估人类乳腺癌 Her2/neu 过表达中的相关性。

相似文献

1
Real-time RT-PCR analysis for evaluating the Her2/neu status in breast cancer.实时 RT-PCR 分析用于评估乳腺癌中的 Her2/neu 状态。
Pathobiology. 2010;77(1):38-45. doi: 10.1159/000272953. Epub 2010 Feb 25.
2
Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.人乳腺癌中HER2及共扩增基因GRB7和MLN64的表达:定量实时逆转录PCR作为免疫组织化学和荧光原位杂交的诊断替代方法
Clin Cancer Res. 2005 Dec 1;11(23):8348-57. doi: 10.1158/1078-0432.CCR-05-0841.
3
Real-time reverse transcription-PCR and fluorescence in-situ hybridization are complementary to understand the mechanisms involved in HER-2/neu overexpression in human breast carcinomas.实时逆转录聚合酶链反应和荧光原位杂交技术相辅相成,有助于了解人类乳腺癌中HER-2/neu过表达所涉及的机制。
Histopathology. 2005 Apr;46(4):431-41. doi: 10.1111/j.1365-2559.2005.02112.x.
4
Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.定量PCR——用于定量特定mRNA和DNA分子的新型诊断工具:与免疫组织化学和荧光原位杂交相比,利用LightCycler实时PCR进行HER2/neu DNA定量分析
Scand J Clin Lab Invest. 2004;64(5):511-22. doi: 10.1080/00365510410002922.
5
HER2 status in breast cancer determined by IHC and FISH: comparison of the results.通过免疫组织化学(IHC)和荧光原位杂交(FISH)检测乳腺癌中的人表皮生长因子受体2(HER2)状态:结果比较
Pol J Pathol. 2004;55(4):165-71.
6
HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.非小细胞肺癌中HER-2/Neu改变:通过实时逆转录聚合酶链反应、荧光原位杂交和免疫组织化学进行的综合评估
Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3645-52.
7
HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.HER-2基因扩增、HER-2和表皮生长因子受体的mRNA及蛋白表达,以及拉帕替尼在转移性乳腺癌女性患者中的疗效
Clin Cancer Res. 2008 Dec 1;14(23):7861-70. doi: 10.1158/1078-0432.CCR-08-1056.
8
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.通过荧光原位杂交和免疫组织化学比较HER2状态,以预测淋巴结阳性乳腺癌患者从基于阿霉素的辅助治疗剂量递增中获益的情况。
J Clin Oncol. 2005 Jul 1;23(19):4287-97. doi: 10.1200/JCO.2005.11.012.
9
Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis.微切割石蜡包埋乳腺癌组织的实时定量PCR:一种HER-2/neu分析的替代方法
J Mol Diagn. 2004 Feb;6(1):42-51. doi: 10.1016/S1525-1578(10)60490-4.
10
Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization.子宫浆液性乳头状癌中HER2/neu状态的测定:免疫组织化学与荧光原位杂交的比较分析
Gynecol Oncol. 2005 Jul;98(1):24-30. doi: 10.1016/j.ygyno.2005.03.041.

引用本文的文献

1
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases.使用定量逆转录聚合酶链反应进行Her2评估能够可靠地识别出乳腺癌病例中未发生扩增的Her2过表达情况。
J Transl Med. 2017 May 1;15(1):91. doi: 10.1186/s12967-017-1195-7.
2
The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer.激光捕获显微切割与逆转录定量聚合酶链反应的组合方法可准确确定乳腺癌中的 HER2 状态。
Biomark Res. 2016 Apr 7;4:8. doi: 10.1186/s40364-016-0062-7. eCollection 2016.
3
ERBB2 in cat mammary neoplasias disclosed a positive correlation between RNA and protein low expression levels: a model for erbB-2 negative human breast cancer.
猫乳腺肿瘤中 ERBB2 的表达:RNA 和蛋白低表达水平之间存在正相关,为人类乳腺癌 erbB-2 阴性模型。
PLoS One. 2013 Dec 26;8(12):e83673. doi: 10.1371/journal.pone.0083673. eCollection 2013.
4
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学会临床实践指南更新。
Arch Pathol Lab Med. 2014 Feb;138(2):241-56. doi: 10.5858/arpa.2013-0953-SA. Epub 2013 Oct 7.
5
Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2.将姐妹鼠乳腺肿瘤细胞系 HH-16 cl.2/1 和 HH-16.cl.4 定义为 Erbb2 的体外细胞模型。
PLoS One. 2012;7(1):e29923. doi: 10.1371/journal.pone.0029923. Epub 2012 Jan 10.
6
HER2 status in breast cancer: experience of a Spanish National Reference Centre.乳腺癌中 HER2 状态:西班牙国家参考中心的经验。
Clin Transl Oncol. 2011 May;13(5):335-40. doi: 10.1007/s12094-011-0663-4.
7
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.免疫组化和分子分析 HER2 状态在乳腺癌中具有高度一致性和互补性。
Br J Cancer. 2011 May 24;104(11):1739-46. doi: 10.1038/bjc.2011.135. Epub 2011 May 3.